Marker Therapeutics Inc (MRKR)

[Gatta-git-it]

I look at Keytruda.. 210 patient clinical .. 69% had positive response.. 22% developed a CR..

Even with the limited safety trial... Marker clearly has far greater response rate and CR.

I hope that this time, with this paper and presentation at ASH in Atlanta.. that attendees and viewers conclude that we have a pipeline of effective meds.. and that orphan drug status along with Fast track granting takes place via FDA to our corporation and Baylor.

Lives are at stake.. not only with AML , but also with so many other Hemotological diseases. Give the opportunity to live as the option. Patients need the hope.. we need the results...